Drugmaker Sanofi to let go of staff at vaccine plants in India as part of review Ruchika Sharma31 Jan 2023 1:30 PM ISTAbout 800 employees could be affected by the decision, two sources familiar with the matter said.
Sanofi Dupixent gets European Commission okay to treat eosinophilic esophagitis Ruchika Sharma30 Jan 2023 4:30 PM ISTDupixent is an injection administered under the skin (subcutaneous injection) at different injection sites.
Sanofi Gets CDSCO Panel Nod To Market Avalglucosidase Alfa Powder for Pompe Disease Dr. Divya Colin28 Jan 2023 6:00 PM ISTNew Delhi: Granting a local Phase III and Phase IV clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Sanofi plans to unveil blood disorder drug this year: Report Ruchika Sharma20 Jan 2023 2:30 PM ISTFrance: French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told...
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
Sanofi gets EMA panel recommendation for Dupixent to treat eosinophilic esophagitis Ruchika Sharma19 Dec 2022 10:30 AM ISTEoE is a chronic, progressive inflammatory disease that damages the esophagus and prevents it from working properly.
Sanofi Dupixent gets European Commission nod for Prurigo Nodularis Ruchika Sharma18 Dec 2022 5:30 PM ISTParis: Regeneron Pharmaceuticals, Inc. and Sanofi have announced that the European Commission (EC) has expanded the marketing authorization for...
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
Britain regulator calls for review of reactions in eyes to Sanofi asthma drug Dupixent Ruchika Sharma30 Nov 2022 5:30 PM ISTEuropean and U.S. health regulators have listed conjunctivitis, an eye irritation that can cause redness and discomfort, as a side effect of Dupixent
Sanofi Dupixent recommended for EU approval by CHMP for prurigo nodularis treatment Ruchika Sharma13 Nov 2022 4:30 PM ISTDupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
Sanofi forecasts faster profit growth on Dupixent, flu vaccine demand Ruchika Sharma30 Oct 2022 10:00 AM ISTParis: French drugmaker Sanofi on Friday forecasted faster earnings growth this year on strong demand for its bestselling drug Dupixent and for...
